And there goes another longevity therapy...SIRT1-deficient cells fail to normally upregulate either the p19ARF senescence regulator or its downstream target p53
(Sorry, can't get full text either)
Posted 28 December 2005 - 06:30 PM
And there goes another longevity therapy...SIRT1-deficient cells fail to normally upregulate either the p19ARF senescence regulator or its downstream target p53
Posted 29 December 2005 - 12:47 AM
Posted 29 December 2005 - 08:07 PM
Posted 29 December 2005 - 08:28 PM
Posted 30 December 2005 - 02:27 AM
Posted 31 December 2005 - 05:37 PM
Posted 31 December 2005 - 08:56 PM
Posted 01 January 2006 - 08:19 AM
Posted 01 January 2006 - 08:28 AM
Posted 01 January 2006 - 03:13 PM
Well, there's a mountain of knowledge out there... p53 is a DNA damage signal integrator, that has three main outcomes, increased DNA repair, senescence or apoptosis. The latter two can shorten life-span, possibly mainly by senescent cell signaling and stem cell depletion, if they occur excessively.Well, I'd have to know more about about how the p19ARF / p53 tumor suppression pathway works
Yes... There is one very interesting mutant called super p53, which effects increased tumor suppression, without the life span shortening. It is tempting to speculate that this might be by shifting the outcome towards DNA repair (see the SENS2 talk by Serrano). Anyway, this has no implication for how not to downregulate tumor suppression with sir1 silencing.I think increased expression of p53 leads to more effective tumor supression but shortens lifespan in animals.
And that would be a great point, if it was joined by some ideas of how this might be possible in prinicple...My point is that the adverse effects on p19ARF / p53 tumor suppression may not necessarily be unavoidable. Perhaps they can be offset, or counter-acted.
Depends on who "we" is. Sirtuin researchers should and sure will continue to do this. But for immortalists, I do not think the evidence warrants placing a top priority on this just yet.I do not think we should merely avoid research on this
It's too crazy hard to do. I know I'm repeating myself, but the key is to target the damage, because damage is so way simpler than the metabolism that causes it, and targeting metabolism cannot reverse pre-existing types of damage that it is not equiped to handle.Perhaps then the key is to specialize in counteracting specific types of cancer caused by specific types of oncogenous activity, while reaping the associated life-extension benefits.
Heh, that should give us some good PR [thumb]done in combination with deletion of Akt or other gene in IGF-1 signaling. And put the worms on caloric restriction:)
I see, here comes the how-to. Well, I don't know. Veronica are you dreaming this, or are you in some position to acutally play with these things?I think that the article also mentioned that deletion of Sir2 actually caused the decrease in amount of mutation with time. Should this be possible cancer prevention?
Interesting, very interesting!in human postmitotic cells like neurons.
Posted 02 January 2006 - 02:34 AM
Posted 03 January 2006 - 02:13 PM
Posted 08 January 2006 - 06:03 AM
Posted 08 January 2006 - 08:19 PM
Posted 10 January 2006 - 11:17 AM
0 members, 1 guests, 0 anonymous users